Journey Strategic Wealth LLC Has $3.16 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Journey Strategic Wealth LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 16.8% during the first quarter, Holdings Channel reports. The fund owned 6,026 shares of the healthcare conglomerate’s stock after purchasing an additional 867 shares during the period. Journey Strategic Wealth LLC’s holdings in UnitedHealth Group were worth $3,156,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of UNH. Norges Bank bought a new position in UnitedHealth Group during the 4th quarter worth approximately $6,375,744,000. GAMMA Investing LLC raised its position in UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate’s stock valued at $4,344,586,000 after purchasing an additional 8,280,404 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in UnitedHealth Group by 36.6% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate’s stock worth $4,346,712,000 after purchasing an additional 2,301,010 shares in the last quarter. Northern Trust Corp boosted its position in shares of UnitedHealth Group by 12.5% in the 4th quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate’s stock worth $4,807,527,000 after purchasing an additional 1,058,488 shares in the last quarter. Finally, Capital International Investors raised its stake in shares of UnitedHealth Group by 6.2% during the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate’s stock valued at $7,899,905,000 after buying an additional 906,365 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of recent research reports. Oppenheimer dropped their price objective on shares of UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating for the company in a research note on Wednesday, May 14th. Hsbc Global Res lowered shares of UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research note on Wednesday, May 21st. Baird R W downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, June 11th. TD Cowen downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price objective for the company. in a report on Monday, May 19th. Finally, Piper Sandler reduced their target price on shares of UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating on the stock in a research report on Tuesday, June 3rd. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus target price of $394.43.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the transaction, the chief executive officer owned 10,398 shares in the company, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the firm’s stock in a transaction dated Friday, May 16th. The stock was bought at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the purchase, the chief executive officer owned 679,493 shares of the company’s stock, valued at approximately $196,081,295.01. This trade represents a 14.63% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 109,408 shares of company stock valued at $31,607,768 over the last quarter. 0.28% of the stock is currently owned by corporate insiders.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $283.36 on Thursday. The company has a market cap of $257.05 billion, a P/E ratio of 12.24, a price-to-earnings-growth ratio of 1.39 and a beta of 0.45. The business has a fifty day moving average of $301.70 and a two-hundred day moving average of $428.82. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a dividend of $2.21 per share. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.12%. UnitedHealth Group’s dividend payout ratio is currently 37.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.